Incidence of nasopharyngeal carcinoma has remained high in endemic regions. Diagnosing
the disease in the early stages requires a high index of clinical acumen and, although most …

The adverse effects of radiation therapy, often integrated with chemotherapy and/or targeted
therapies, on the skin include severe acute and chronic dermatitis associated with pain …

Acute dermatitis is the most common radio-induced side effect during treatment for head and
neck cancer. The use of a wide variety of agents is reported to handle skin toxicity. Our aim …

Objective Latent membrane protein 1 (LMP1) is an oncogene of Epstein–Barr virus (EBV).
Although EBV is associated with 90% of nasopharyngeal carcinoma (NPC), the reported …

Positron emission tomography-computed tomography is replacing conventional imaging in
the initial M staging of nasopharyngeal carcinoma. Its usefulness in response evaluation …

Oral mucositis causes substantial morbidity during head and neck radiotherapy, especially
nasopharyngeal carcinoma. During radiotherapy, patients develop severe oral mucositis …

The majority of nasopharyngeal carcinoma (NPC) patients present at locally advanced
stage. The poor prognosis has led to increasing interests in exploring the use of …

Abstract Purpose: 130-nm albumin–bound paclitaxel (nab-paclitaxel) is a novel solvent-free
albumin-bound paclitaxel, designed to avoid solvent-related toxicity. Nab-paclitaxel has …

Objective This study was conducted to investigate the efficacy and safety of using a
concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of …

Southeast Asia is a region with high incidence of nasopharyngeal carcinoma (NPC).
Paclitaxel is the mainstay for the treatment of advanced nasopharyngeal cancer. The …